Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evotec Earns Boehringer Milestone | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Evotec Earns Boehringer Milestone

Evotec AG has reached a milestone triggering a $2.6 million payment in its research alliance with Boehringer Ingelheim.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Evotec AG has reached a milestone triggering a $2.6 million payment in its research alliance with Boehringer Ingelheim. The milestone was for the transition of an oncology program into lead optimization.

Dr. Mario Polywka, chief operating officer of Evotec, said, “This is the 11th milestone achieved as part of this alliance with Boehringer Ingelheim and the second against an oncology target. We continue to enjoy a very rich scientific partnership with Boehringer Ingelheim and look forward to continued success through our joint project teams in the coming years.”

In 2004, the two companies entered into a multi-year, multi-target drug discovery alliance to jointly identify and develop preclinical candidates for the treatment of various disease areas including CNS, inflammation, cardiometabolic and respiratory diseases.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics